Imaging & Diagnostics

Can Tech Partnership with Epic Transform Surgical Care Quality?
Imaging & Diagnostics Can Tech Partnership with Epic Transform Surgical Care Quality?

In an era where technology increasingly shapes the healthcare landscape, the partnership between the American College of Surgeons (ACS) and Epic's Community Registries Platform promises to redefine surgical care quality. Standing at the forefront of clinical data utilization, the ACS has

IVD Contract Manufacturing: Navigating Growth and Innovation
Imaging & Diagnostics IVD Contract Manufacturing: Navigating Growth and Innovation

The world of in vitro diagnostics (IVD) is rapidly transforming, driven by the urgent need for accurate and timely diagnostic solutions in the healthcare sector. At the heart of this evolution lies the IVD Contract Manufacturing Services Market, a critical component in the healthcare supply chain.

Belgium's Radiology Revamp: Evidence-Based Guidelines Lead
Imaging & Diagnostics Belgium's Radiology Revamp: Evidence-Based Guidelines Lead

The Belgian Medical Imaging Platform (BELMIP) is leading an ambitious initiative aimed at revolutionizing radiology practices in Belgium by integrating evidence-based guidelines into clinical workflows. This effort seeks to address the increasing number of computed tomography (CT) scans performed

How Can Innovative Procedures Transform Cancer Outcomes?
Imaging & Diagnostics How Can Innovative Procedures Transform Cancer Outcomes?

The journey of pancreatic cancer patient David Allard presents an extraordinary example of how innovative medical interventions can dramatically alter cancer outcomes. Initially diagnosed with stage IV pancreatic cancer, David faced a dire prognosis: less than six months to live. Refusing to accept

Quest Diagnostics to Launch FDA-Approved Alzheimer's Blood Test
Imaging & Diagnostics Quest Diagnostics to Launch FDA-Approved Alzheimer's Blood Test

In a significant advancement for Alzheimer's diagnostics, Quest Diagnostics is set to launch an FDA-approved blood test designed to detect amyloid pathology with remarkable precision. This pioneering test, developed by Fujirebio Diagnostics, represents a milestone as it receives FDA clearance,

How Will Radiopharmaceuticals Transform PET Imaging by 2034?
Imaging & Diagnostics How Will Radiopharmaceuticals Transform PET Imaging by 2034?

Positron emission tomography (PET) imaging has emerged as a vital tool in modern medical diagnostics, offering insights into the human body's molecular and cellular functions. At the forefront of this advancement are radiopharmaceuticals, specialized compounds that combine a radionuclide with a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later